EC 1.14.11.68 ([histone H3]-trimethyl-L-lysine(27) demethylase) inhibitor

Term ID

CHEBI:233404

Synonyms

[histone H3]-N(6),N(6),N(6)-trimethyl-L-lysine-27,2-oxoglutarate:oxygen oxidoreductase inhibitor
[histone H3]-N(6),N(6),N(6)-trimethyl-L-lysine-27,2-oxoglutarate:oxygen oxidoreductase inhibitors
[histone H3]-trimethyl-L-lysine(27) demethylase inhibitor
[histone H3]-trimethyl-L-lysine(27) demethylase inhibitors
EC 1.14.11.68 ([histone H3]-trimethyl-L-lysine(27) demethylase) inhibitors
EC 1.14.11.68 inhibitor
EC 1.14.11.68 inhibitors
JMJD3 inhibitor
JMJD3 inhibitors
KDM6A inhibitor
KDM6A inhibitors
KDM6C inhibitor
KDM6C inhibitors
UTX inhibitor
UTX inhibitors
UTY inhibitor
UTY inhibitors

Definition

An EC 1.14.11.* (oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors) inhibitor that interferes with the action of [histone H3]-trimethyl-L-lysine(27) demethylase (EC 1.14.11.68).

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: EC 1.14.11.* (oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors) inhibitor

EC 1.14.11.* (oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors) inhibitor Show first 5 Terms
inverse has_role: GSK-J1 GSK-J4

GSK-J1 GSK-J4 Show first 5 Terms

Phenotype

Phenotype resulting from EC 1.14.11.68 ([histone H3]-trimethyl-L-lysine(27) demethylase) inhibitor

Phenotype where environments contain EC 1.14.11.68 ([histone H3]-trimethyl-L-lysine(27) demethylase) inhibitor

Phenotype modified by environments containing EC 1.14.11.68 ([histone H3]-trimethyl-L-lysine(27) demethylase) inhibitor

Phenotype affecting EC 1.14.11.68 ([histone H3]-trimethyl-L-lysine(27) demethylase) inhibitor

Human Disease Model